Sample Name
Sample Code
Sample Name
Sample Code
Sample Name
Sample Code
4
BIDU-SW
09888
5
JD HEALTH
06618
| (Q6)Sep 30, 2025 | (FY)Mar 31, 2025 | (Q6)Sep 30, 2024 | (FY)Mar 31, 2024 | (Q6)Sep 30, 2023 | (FY)Mar 31, 2023 | (Q6)Sep 30, 2022 | (FY)Mar 31, 2022 | (Q6)Sep 30, 2021 | (FY)Mar 31, 2021 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Cash flow from operating activities | ||||||||||
| Earning before tax | ---- | -222.81%-123.99M | ---- | -728.76%-38.41M | ---- | 111.65%6.11M | ---- | 70.76%-52.43M | ---- | 29.87%-179.32M |
| Profit adjustment | ||||||||||
| Interest (income) - adjustment | ---- | -183.43%-3.51M | ---- | -58.18%-1.24M | ---- | 14.35%-782K | ---- | 37.76%-913K | ---- | 25.76%-1.47M |
| Impairment and provisions: | ---- | -10.10%5M | ---- | -50.68%5.57M | ---- | -38.21%11.29M | ---- | -74.10%18.27M | ---- | 6.46%70.53M |
| -Impairment of property, plant and equipment (reversal) | ---- | 9.05%482K | ---- | 183.33%442K | ---- | -49.35%156K | ---- | -92.05%308K | ---- | -42.96%3.87M |
| -Impairmen of inventory (reversal) | ---- | -116.78%-404K | ---- | -69.60%2.41M | ---- | -50.82%7.92M | ---- | 8.56%16.11M | ---- | 43.08%14.84M |
| -Impairment of trade receivables (reversal) | ---- | ---- | ---- | -2,741.41%-3.38M | ---- | 106.40%128K | ---- | -236.43%-2M | ---- | --1.47M |
| -Other impairments and provisions | ---- | -19.21%4.93M | ---- | 97.95%6.1M | ---- | -19.98%3.08M | ---- | -92.36%3.85M | ---- | 2.57%50.35M |
| Revaluation surplus: | ---- | 868.56%40.92M | ---- | 73.22%-5.32M | ---- | -226.13%-19.88M | ---- | -121.07%-6.1M | ---- | 147.11%28.93M |
| -Fair value of investment properties (increase) | ---- | 868.56%40.92M | ---- | 73.22%-5.32M | ---- | -226.13%-19.88M | ---- | -121.07%-6.1M | ---- | 147.11%28.93M |
| Asset sale loss (gain): | ---- | 201.82%280K | ---- | -3,337.50%-275K | ---- | 72.41%-8K | ---- | 65.88%-29K | ---- | -109.43%-85K |
| -Loss (gain) on sale of property, machinery and equipment | ---- | 201.82%280K | ---- | -3,337.50%-275K | ---- | 72.41%-8K | ---- | 65.88%-29K | ---- | -109.43%-85K |
| Depreciation and amortization: | ---- | -1.49%96.55M | ---- | 25.08%98.02M | ---- | 6.81%78.37M | ---- | -35.68%73.37M | ---- | -46.48%114.08M |
| Financial expense | ---- | 14.30%39.78M | ---- | 101.93%34.81M | ---- | 61.36%17.24M | ---- | -30.81%10.68M | ---- | -39.66%15.44M |
| Special items | ---- | 102.37%26K | ---- | 85.35%-1.1M | ---- | 58.03%-7.5M | ---- | -125.14%-17.87M | ---- | -296.22%-7.94M |
| Operating profit before the change of operating capital | ---- | -40.18%55.06M | ---- | 8.51%92.04M | ---- | 239.63%84.82M | ---- | -37.81%24.98M | ---- | -37.22%40.16M |
| Change of operating capital | ||||||||||
| Inventory (increase) decrease | ---- | 12.93%-13.7M | ---- | -165.98%-15.73M | ---- | -55.92%23.85M | ---- | -62.95%54.1M | ---- | 119.88%146.02M |
| Accounts receivable (increase)decrease | ---- | -89.05%197K | ---- | 123.72%1.8M | ---- | -177.21%-7.58M | ---- | 25.17%9.82M | ---- | 33.99%7.85M |
| Accounts payable increase (decrease) | ---- | -186.34%-14.16M | ---- | 1,262.93%16.4M | ---- | -80.47%1.2M | ---- | 166.91%6.16M | ---- | 53.91%-9.21M |
| Advance payment increase (decrease) | ---- | 133.73%224K | ---- | -179.90%-664K | ---- | -27.11%831K | ---- | 4,660.00%1.14M | ---- | 90.74%-25K |
| prepayments (increase)decrease | ---- | 253.50%5M | ---- | -126.13%-3.26M | ---- | 18.55%12.48M | ---- | -53.66%10.52M | ---- | 26.11%22.71M |
| Cash from business operations | ---- | -63.98%32.63M | ---- | -21.64%90.58M | ---- | 8.31%115.6M | ---- | -48.57%106.72M | ---- | 54.86%207.51M |
| Hong Kong profits tax paid | ---- | 4.17%-574K | ---- | -8.51%-599K | ---- | 31.00%-552K | ---- | -109.04%-800K | ---- | 606.88%8.85M |
| Other taxs | ---- | 121.39%40K | ---- | -484.38%-187K | ---- | 75.19%-32K | ---- | 80.75%-129K | ---- | 75.05%-670K |
| Interest paid - operating | ---- | -4.28%-8.11M | ---- | -181.00%-7.78M | ---- | 4.75%-2.77M | ---- | 48.94%-2.91M | ---- | ---5.69M |
| Special items of business | 241.06%28.65M | ---- | -161.95%-20.31M | ---- | -28.24%32.78M | ---- | -18.67%45.68M | ---- | -40.99%56.17M | ---- |
| Net cash from operations | 241.06%28.65M | -70.75%23.99M | -161.95%-20.31M | -26.93%82.01M | -28.24%32.78M | 9.09%112.24M | -18.67%45.68M | -51.00%102.89M | -40.99%56.17M | 62.07%209.99M |
| Cash flow from investment activities | ||||||||||
| Interest received - investment | ---- | 14,892.31%1.95M | ---- | -18.75%13K | ---- | -44.83%16K | ---- | -6.45%29K | ---- | -47.46%31K |
| Decrease in deposits (increase) | ---- | -385.84%-10.84M | ---- | ---2.23M | ---- | ---- | ---- | ---- | ---- | ---- |
| Sale of fixed assets | ---- | -91.09%31K | ---- | 2,220.00%348K | ---- | -78.26%15K | ---- | -18.82%69K | ---- | 183.33%85K |
| Purchase of fixed assets | ---- | 59.23%-2.5M | ---- | -280.60%-6.14M | ---- | -32.43%-1.61M | ---- | 76.20%-1.22M | ---- | 45.47%-5.12M |
| Other items in the investment business | 103.78%595K | ---- | -285.22%-15.74M | ---- | -447.72%-4.09M | ---- | -57.38%-746K | ---- | 88.24%-474K | ---- |
| Net cash from investment operations | 103.78%595K | -41.87%-11.36M | -285.22%-15.74M | -406.26%-8.01M | -447.72%-4.09M | -41.25%-1.58M | -57.38%-746K | 77.61%-1.12M | 88.24%-474K | 95.79%-5M |
| Net cash before financing | 181.12%29.24M | -82.94%12.62M | -225.63%-36.05M | -33.13%74.01M | -36.14%28.69M | 8.74%110.66M | -19.32%44.93M | -50.35%101.77M | -38.90%55.69M | 1,811.84%204.99M |
| Cash flow from financing activities | ||||||||||
| New borrowing | ---- | 62.11%810.28M | ---- | 102.22%499.84M | ---- | 20.19%247.17M | ---- | -8.00%205.64M | ---- | -69.89%223.53M |
| Refund | ---- | -46.02%-688.8M | ---- | -113.02%-471.72M | ---- | 0.81%-221.45M | ---- | 12.14%-223.25M | ---- | 56.77%-254.09M |
| Interest paid - financing | ---- | -15.80%-31.3M | ---- | -87.48%-27.03M | ---- | -85.39%-14.42M | ---- | 21.83%-7.78M | ---- | 28.79%-9.95M |
| Dividends paid - financing | ---- | ---- | ---- | ---12.59M | ---- | ---- | ---- | ---- | ---- | ---- |
| Other items of the financing business | -176.04%-30.06M | ---- | 176.24%39.53M | ---- | -15.06%-51.85M | ---- | 31.46%-45.07M | ---- | 9.83%-65.75M | ---- |
| Net cash from financing operations | -176.04%-30.06M | 94.46%-5.82M | 176.24%39.53M | -33.09%-105.15M | -15.06%-51.85M | 44.51%-79.01M | 31.46%-45.07M | 24.06%-142.37M | 9.83%-65.75M | -353.14%-187.48M |
| Effect of rate | -116.67%-7K | 95.34%-28K | -57.58%42K | -200.50%-601K | 125.92%99K | -253.85%-200K | -148.54%-382K | -95.84%130K | 154.69%787K | 194.26%3.13M |
| Net Cash | -123.49%-819K | 121.83%6.8M | 115.05%3.49M | -198.37%-31.14M | -17,443.18%-23.16M | 177.97%31.66M | 98.69%-132K | -331.89%-40.6M | -155.22%-10.06M | 157.13%17.51M |
| Begining period cash | 53.75%13.13M | -83.32%6.36M | -77.59%8.54M | 473.75%38.1M | 271.35%38.1M | -85.91%6.64M | -78.23%10.26M | 77.95%47.11M | 77.95%47.11M | -52.78%26.48M |
| Cash at the end | 1.95%12.3M | 106.55%13.13M | -19.78%12.07M | -83.32%6.36M | 54.33%15.04M | 473.75%38.1M | -74.25%9.75M | -85.91%6.64M | -15.93%37.84M | 77.95%47.11M |
| Cash balance analysis | ||||||||||
| Cash and bank balance | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- | -15.93%37.84M | ---- |
| Cash and cash equivalent balance | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- | -15.93%37.84M | 77.95%47.11M |
| Currency Unit | HKD | HKD | HKD | HKD | HKD | HKD | HKD | HKD | HKD | HKD |
| Accounting Standards | HKAS | HKAS | HKAS | HKAS | HKAS | HKAS | HKAS | HKAS | HKAS | HKAS |
| Auditor | -- | Ernst & Young | -- | Ernst & Young | -- | Ernst & Young | -- | Ernst & Young | -- | Deloitte Guan Huang Chen Fang Certified Public Accountants |
FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.
Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.